Scholars Central

ArticlePublished 2012

Simultaneous Estimation of Aliskiren and Amlodipine in Tablet Dosage form by UV Spectroscopy

Authors: Das Paramita, Patel Sandip, P.P. Radhika, Subramanyam E.V.S, A. Sharbaraya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Two simple, sensitive, rapid and accurate analytical methods have been developed for the simultaneous of ALISKIREN and AMLODIPINE in marketed formulation of pharmaceutical dosage forms. The Q-analysis based on measurement of absorptivity at 279nm and 289nm (as an isoabsorptive point). The second method developed and validated of simultaneous equation using 279/361nm. ALISKIREN and AMLODIPINE at their respective λmax 279nm and 361nm and at iso absorptive point 289nm show linearity in a concentration range of 20-100μg/ml and 5- 25μg/ml.Recovery studies range from 99.51% for Aliskiren and 99.51% for Amlodipine in case of simultaneous equation method Aliskiren was 100.10% and Amlodipine was 100.47%.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Das Paramita”
  • BylineArticles whose byline prints “Patel Sandip”
  • BylineArticles whose byline prints “P.P. Radhika”
  • BylineArticles whose byline prints “Subramanyam E.V.S”
  • BylineArticles whose byline prints “A. Sharbaraya”